RESEARCH-USE BIOSIMILAR ANTIBODY
Indatuximab
Antibody-drug conjugate · IgG4
Indatuximab is a CHO-expressed chimeric antibody that targets Syndecan-1/CD138. The predicted molecular weight (MW) of Indatuximab is 145.5 kDa. The isotype control for Indatuximab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
TARGETSDC1
YAntibody-drug conjugate
CATALOGSC-BS-482
CATALOG NUMBERSC-BS-482
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Indatuximab is a CHO-expressed chimeric antibody that targets Syndecan-1/CD138. The predicted molecular weight (MW) of Indatuximab is 145.5 kDa. The isotype control for Indatuximab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
Indatuximab is a recombinant research-use antibody directed against SDC1.